DexCom Inc

DXCM: XNAS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
#<&LOCK|YV@?LLOCK|L#B!hv&#

DexCom Earnings: Slower Growth and Higher Input Costs Could Weigh on 2026

DexCom's first-quarter results included constant-currency revenue growth of 12% to $1.19 billion, as well as adjusted operating income of 22%, up 840 basis points from the prior-year period.

Sponsor Center